Caused mainly by herpes simplex virus type 2 (HSV-2), the disease is characterized by recurrent outbreaks in which the ...
A study investigating GSK’s investigational herpes simplex virus (HSV) vaccine candidate failed to meet its primary efficacy endpoint.
GSK Plc has halted development of its herpes simplex virus vaccine, GSK3943104, after it failed to meet efficacy goals in ...
DeepWell Digital Therapeutics received 510 (k) clearance from the FDA on its biofeedback software development kit for use in ...
As students prepare to return to university, Well Pharmacy have shared the tell-tale signs of five common STIs. Millions of ...
The British pharma said its shot didn’t meet the efficacy goals of a Phase 2 study. Elsewhere, Zealand reported more obesity drug data and Lilly appointed a company veteran as its new CFO.
UK government’s £500m taxpayer-backed deal for steelworks secures long-term future of Port Talbot but unable to secure guarantees to save 2,500 jobs ...